Comment on CMS-2026-1256-0002

Cook Group, Inc.OtherAdvocacy
Summary: Cook Group, a medical technology manufacturer, expresses a mixed position on the proposed rule. They oppose the repeal of the alternative NTAP and Transitional Pass-Through pathway for FDA Breakthrough Devices due to concerns over patient access, but they support the adoption of Unique Device Identifiers (UDI) for implantable medical devices to improve patient safety and evidence generation.
See attached file(s)

View on Regulations.gov